ACE and Hypertension: The results demonstrated that angiotensin-converting enzyme (ACE) inhibitors and angiotensin II type 1 receptor antagonists (ARB) reduced IA rupture rate without altering systemic hypertension, which further suggests the activation of a regional vascular RAAS system in IA rupture [55].